Pfizer Suspends Osteoarthritis Trials of Pain Drug After FDA Request - WSJ.com
Pfizer Inc. said it would suspend osteoarthritis trials of its pain drug tanezumab after a "small number" of reports that patients' ailments worsened to the point of needing joint replacement.
No comments:
Post a Comment